About Phenomenex
Phenomenex is a Healthcare company based in Torrance (United States) founded in 1982, and was acquired by Danaher in October 2016. Analytical chemistry solutions for separation and purification applications. The company has 58 employees. Its website phenomenex.com draws about 162 thousand monthly visits. Its Indian entity Phenomenex India Private Limited reported revenue of ₹122 Cr. Phenomenex offers products and services including Biozen LC Columns, Zebron GC Columns, and Strata-X PRO SPE Products. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Chromatography. Its competitors include ChromaTan, Sepax Technologies and Sepragen; 3 of its 3 listed competitors have raised funding.
Company details
Phenomenex specializes in chromatography solutions for research applications. Their product range covers the whole spectrum of chromatography applications including HPLCUPLC (reverse phase, normal phase, chiral, size exclusion, HILIC, Ion-exchange and Ion-exclusion), GC (GC columns, Inlet liners and other accessories), SPE, protein precipitation, phospholipid removal, filtration, SLE, BGR, SFC, and preparative columns. The company also manufactures bulk media, oligonucleotides, and reagents for amino acid analysis.
- Headquarters Torrance, United States
- Employees 58
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website phenomenex.com
- Social LinkedIn X Facebook Instagram YouTube
- Acquired by Danaher (Oct 2016)
- Legal Name Phenomenex India Private Limited
- Date of Incorporation 03 Dec, 2010
- Jurisdiction Hyderabad, Telangana, India
Associated legal entities of Phenomenex
Phenomenex operates through Phenomenex India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Phenomenex India Private Limited CIN U51900TG2010FTC071521 | Active | 03 Dec 2010 | Hyderabad, Telangana | ₹122 Cr | 58 | 3 | View details |
Products & Services of Phenomenex
Phenomenex offers a comprehensive portfolio of products and services, including Biozen LC Columns, Zebron GC Columns, and Strata-X PRO SPE Products.
Columns for biologics analysis in separation processes
Low bleed separations for gas chromatography applications
Tools to reduce sample clean-up time efficiently
Apps and channels of Phenomenex
its YouTube channel Phenomenex has 3.96K subscribers and 30 videos.
Videos from Phenomenex
The most watched videos on Phenomenex's YouTube channel, Phenomenex (3.96K subscribers). Click a video to play it here.
More on Phenomenex.
Investors in Phenomenex
Phenomenex has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Danaher.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Dental equipment and medical instruments are manufactured for therapeutic areas. | 1969 | danaher.com |
Investor details for Phenomenex
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Phenomenex India Private Limited (Phenomenex)
Phenomenex India Private Limited is the primary company behind Phenomenex. The board of Phenomenex India Private Limited currently have 3 directors; the longest-serving is Shaik Mohammad Sadak, appointed in 2023. 17 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Shaik Mohammad Sadak DIN 10100630 | Director | 05 Apr 2023 | 3 yrs 6 mo | Phenomenex India Private Limited |
| Hema Sundarraj DIN 09138718 | Additional Director | 20 Jan 2025 | 1 yr 9 mo | Phenomenex India Private Limited |
| Kaveh Kahen DIN 09322267 | Additional Director | 20 Jan 2025 | 1 yr 9 mo | Phenomenex India Private Limited |
People of Phenomenex
175 people are tracked at Phenomenex (21 in leadership, 154 in team); the tracked headcount is 58.
| Name | Role | Group |
|---|---|---|
Jim Tsang | Director Of Business Software Solutions | Leadership |
Monique Minner | Director Grc/it Ops | Leadership |
Hazel Simpson | Director HR & Strategic Talent Management | Leadership |
Lori Chehade | Vice President Global Human Resources | Leadership |
Kevin Hughes | Creative Director | Leadership |
Lauryn Bailey | Vice President, Global Sales & Marketing | Leadership |
Crystal Holt | Director, Global Strategic Marketing | Leadership |
Siming Xu | Director, Global Sales Operations & Strategy | Leadership |
Nancy Ramirez-Ortega | Director, Global Digital Marketing | Leadership |
Jiong Wu | Vp, R&d | Leadership |
Vincent Henry | Sales Director, Europe | Leadership |
Ben Atkins | Sales Director | Leadership |
Brad Turek | Sr. Director Sales - Americas | Leadership |
Chiarina M. | Director, Asia Pacific, Japan | Leadership |
Ed Currant | Director Of Sales - North America | Leadership |
| Chief Financial Officer | Leadership | |
Erica Safan | Director, Customer Experience | Leadership |
Emmet Welch | Senior Director, R&d | Leadership |
Jason Anspach | Director - Research And Open Innovation | Leadership |
Charalampos-Philip Iosifidis | Business Partner | Leadership |
155 more people are available in the full profile.
Complete people profiles for Phenomenex
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Phenomenex
Figures of Phenomenex India Private Limited, the primary company behind Phenomenex, for FY 2025. Revenue was ₹122 Cr (+13% year on year). Net profit was ₹8.81 Cr (7% margin). EBITDA was ₹12.79 Cr (10% margin). Revenue has grown at a compounded annual rate of +6% over three years and +9% over five years.
- ₹122 CrRevenue · FY 2025 · +13% YoY
- ₹8.81 CrNet profit · 7% margin
- ₹12.79 CrEBITDA · 10% margin
- ₹4.46 CrPaid-up capital
- 58Employees (provident fund records)
- +6%Revenue CAGR, 3 years
- +9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Phenomenex India Private Limited are on its company page.
Detailed financial statements for Phenomenex
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Phenomenex
2 dated milestones of Phenomenex across 34 years, from founding to its latest funding, stage changes and deals.
- Founded Phenomenex is founded.
- Exit Acquired by Danaher.
Competitors of Phenomenex
Phenomenex has 3 listed competitors in our database, 3 of them funded. They include ChromaTan, Sepax Technologies and Sepragen.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| chromatan.com | 2009 | State College, United States | $5.32M | Continuous countercurrent tangential chromatography separation technology is developed. | ||
| sepax-tech.com | 2002 | Newark, United States | $109.24M | 57 | Solutions for chromatographic biomolecular separation are developed and provided. | |
| sepragen.com | 1987 | Hayward, United States | $5M | 19 | Biomolecular separation technologies are enabled for bioprocessing applications. |
Detailed competitors of Phenomenex
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Phenomenex
The website of Phenomenex (phenomenex.com) receives about 162.1K visits a month.
- Monthly visits162.1K
▲ 47.8% vs previous month
Websites whose visitors overlap most with Phenomenex. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| restek.com | 100% | #303,284 | View details | ||
| sigmaaldrich.com | 91% | 4.4M | #15,208 | View details | |
| waters.com | 86% | 416.8K | #124,184 | View details | |
| optimizetech.com | 85% | 2.9K | #6,049,343 | View details | |
| perkinelmer.com | 84% | 164.5K | #258,286 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Phenomenex
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Phenomenex (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Phenomenex
Complete news archive for Phenomenex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Phenomenex
Phenomenex was founded in 1982.
Phenomenex is headquartered in Torrance, United States. It is registered at Torrance, California, United States.
Phenomenex has 58 employees.
The primary company behind Phenomenex, Phenomenex India Private Limited, reported revenue of ₹122 Cr for FY 2025, up 13% year on year.
Phenomenex specializes in chromatography solutions for research applications. Their product range covers the whole spectrum of chromatography applications including HPLCUPLC (reverse phase, normal phase, chiral, size exclusion, HILIC, Ion-exchange and Ion-exclusion), GC (GC columns, Inlet liners and other accessories), SPE, protein precipitation, phospholipid removal, filtration, SLE, BGR, SFC, and preparative columns. The company also manufactures bulk media, oligonucleotides, and reagents for amino acid analysis.
Phenomenex's top competitors include ChromaTan, Sepragen and Sepax Technologies.
Phenomenex offers Biozen LC Columns, Zebron GC Columns, and Strata-X PRO SPE Products.
Phenomenex has 1 investor. Key investors include Danaher.
Phenomenex operates through Phenomenex India Private Limited.
Yes. Phenomenex was acquired by Danaher in October 2016.
The legal entities of Phenomenex currently have 3 directors, including Hema Sundarraj, Kaveh Kahen, Shaik Mohammad Sadak.
The website of Phenomenex receives about 162 thousand visits a month.